System and method for intranasal administration of lorazepam
US6610271B2 · kind B2 · utility
39Cited by
12References
28Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 20, 2001 |
| Grant date | Aug 26, 2003 |
| Priority date | — |
| Expiry date | Feb 20, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic composition of lorazepam and its pharmaceutically acceptable derivatives are provided for intranasal administration of at least one predetermined volumetric unit dose in the form of a spray by means that delivers one or more therapeutically prescribed unit doses that are highly accurate as to the volume discharged and which leave no significant quantity of the composition in the delivery means.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.